News Morphic Holding, Inc.

Equities

MORF

US61775R1059

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-18 pm EDT			5-day change	1st Jan Change
27.51 ^USD	-1.29%		-9.27%	-4.74%

Mar. 19	Morphic Holding Names Simon Cooper as Chief Medical Officer	MT
Mar. 19	Morphic Therapeutic Appoints Simon Cooper as Chief Medical Officer	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Ademi LLP Investigates Claims of Securities Fraud against Morphic Holding, Inc.	Apr. 02	PR
Morphic Holding, Inc. (MORF) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings	Apr. 02	BU
Morphic Holding, Inc. (MORF) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings	Mar. 26	BU
Morphic Holding Names Simon Cooper as Chief Medical Officer	Mar. 19	MT
Morphic Appoints Dr. Simon Cooper as Chief Medical Officer	Mar. 19	AQ
Morphic Therapeutic Appoints Simon Cooper as Chief Medical Officer	Mar. 19	CI
Morphic to Participate in March Investor Conferences	Mar. 05	AQ
Morphic Holding's Full Year 2023 Net Loss Widens, Collaboration Revenue Falls	Feb. 22	MT
Morphic Holding, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 22	CI
Morphic Announces Corporate Highlights and Financial Results for the Full Year 2023	Feb. 22	AQ
North American Morning Briefing : Stock Futures -2-	Feb. 21	DJ
Law Offices of Howard G. Smith Announces Investigation of Morphic Holding, Inc. (MORF) on Behalf of Investors	Jan. 11	BU
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Morphic Holding, Inc. (MORF) on Behalf of Investors	Jan. 10	BU
Transcript : Morphic Holding, Inc. Presents at J.P. Morgan 42nd Annual Healthcare Conference 2024, Jan-10-2024 03:45 PM	Jan. 10
The Law Offices of Frank R. Cruz Announces Investigation of Morphic Holding, Inc. (MORF) on Behalf of Investors	Jan. 04	BU
Morphic to Present at the 42nd Annual J.P. Morgan Healthcare Conference	Jan. 03	AQ
Morphic Ethical Equities Fund Buys Back Shares	Dec. 27	MT
Citigroup Starts Morphic Holding With Buy Rating, $46 Price Target	Dec. 08	MT
Robbins LLP Reminds MORF Investors that it is Investigating Morphic Holdings, Inc. on Behalf of Investors	Dec. 01	BU
Morphic Holding, Inc. Reminder: Robbins LLP is Investigating MORF on Behalf of Investors	Nov. 22	BU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Morphic Holding, Inc.

Equities

MORF

US61775R1059

Summary

Filters